 DCC has found to be a useful prognostic marker for late stage colorectal carcinoma in some studies, but unhelpful in others.Currently the American Society of Clinical Oncology does not recommend using DCC as a marker due to insufficient classification data.A recent review of over two dozen 18q LOH-survival studies concluded that there was a significant amount of inconsistency between the data sets.